Internal Medicine · Elmhurst, NY
NPI
1609882000
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
8712 58th Ave
Elmhurst, NY, 11373
Phone (718) 426-4800
Groups this clinician bills Medicare through
Medicare paid, 2024
$470K
6,821 services
Medicare patients, 2024
606
Average age 78
Drug cost, 2024
$2.8M
41,332 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bhaskar R Yeturu was code 99308 (snf e&m), 3,303 times for 295 patients. In total Bhaskar R Yeturu billed 6,821 services in 27 codes, and Medicare paid $470K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-09-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Office | 3,303 | 295 | $63.03 | $208K |
| 99348 Home E&M - New and Established | Office | 2,088 | 208 | $63.95 | $134K |
| 99309 SNF E&M | Office | 260 | 178 | $58.65 | $15K |
| 99305 SNF E&M | Office | 203 | 136 | $115.16 | $23K |
| 99233 Hospital E&M - Subsequent | Facility | 136 | 77 | $102.58 | $14K |
| 99306 SNF E&M | Office | 128 | 125 | $156.50 | $20K |
| 99349 Home E&M - New and Established | Office | 116 | 107 | $71.19 | $8,258 |
| 99214 Office E&M - Established | Office | 89 | 27 | $111.53 | $9,926 |
| 99315 SNF E&M | Office | 82 | 78 | $66.80 | $5,477 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 82 | 54 | $179.90 | $15K |
| 90658 Vaccine Product | Office | 59 | 59 | $21.42 | $1,264 |
| G0008 Administration of influenza virus vaccine | Office | 59 | 59 | $36.42 | $2,149 |
| 99232 Hospital E&M - Subsequent | Facility | 55 | 44 | $68.13 | $3,747 |
| 36415 Venipuncture Blood Collection | Office | 51 | 25 | $8.65 | $441 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 31 | 30 | $36.63 | $1,135 |
By year: 2022 $474K for 5,962 services; 2023 $429K for 6,256 services; 2024 $470K for 6,821 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 51 | 25 | $8.65 | $441 |
Medicare prescription drug claims, 2024
In 2024, the drug Bhaskar R Yeturu prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,710 prescriptions and refills. In total Bhaskar R Yeturu wrote 41,332 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,710 | 2,828 | 315 | $34K |
| Amlodipine Besylate Generic | 1,738 | 1,812 | 192 | $12K |
| Tamsulosin Hcl Generic | 1,624 | 1,682 | 177 | $27K |
| Pantoprazole Sodium Generic | 1,508 | 1,524 | 207 | $23K |
| Metoprolol Succinate Generic | 1,275 | 1,415 | 173 | $22K |
| Losartan Potassium Generic | 1,201 | 1,293 | 147 | $11K |
| Levothyroxine Sodium Generic | 1,098 | 1,158 | 115 | $12K |
| Finasteride Generic | 1,076 | 1,120 | 116 | $13K |
| Metoprolol Tartrate Generic | 1,025 | 1,073 | 112 | $6,779 |
| Furosemide Generic | 855 | 872 | 122 | $4,800 |
| Gabapentin Generic | 826 | 846 | 103 | $9,522 |
| Eliquis Apixaban | 774 | 792 | 84 | $336K |
| Januvia Sitagliptin Phosphate | 665 | 709 | 66 | $317K |
| Metformin Hcl Generic | 638 | 706 | 87 | $5,827 |
| Lisinopril Generic | 582 | 610 | 69 | $4,517 |
Brand drugs: 5,828 claims; generic drugs: 35,062 claims; opioid claims: 561.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Bhaskar R Yeturu were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.